EVIDENCE RECORD · 0bb92ccfd8251b776a8f

Peptide Crafters

Tesamorelin

Tesamorelin (10mg)

● PB preserved No lab lookup Exact product match 7 versions
01 / STRUCTURED EVIDENCE

What this certificate reports

Each value keeps its acquisition path attached. Missing fields are shown rather than inferred. Confidence describes extraction and attribution—not result quality.

Compound Tesamorelin
Document extracted · 88% confidence
Labeled quantity 10 mg
Vendor stated · 70% confidence
Measured quantity 11.22 mg
Document extracted · 82% confidence
Per-vial quantity results Vial 1: 11.18 mg · Vial 2: 11.26 mg · Vial 3: 11.22 mg
Document extracted · 94% confidence
Purity 99.7%
Document extracted · 90% confidence
Per-vial purity results Vial 1: 99.65% · Vial 2: 99.657% · Vial 3: 99.79%
Document extracted · 94% confidence
Identity Panel reported
Vendor stated · 80% confidence
Batch / lot PC-G-TS10
Document extracted · 84% confidence
Report number 63393
Document extracted · 84% confidence
Sample received date Apr 25, 2025
Document extracted · 90% confidence
Testing date / window 2025-04-28
Document extracted · 86% confidence
Report date Not extracted
No value captured
Vendor COA date Not extracted
No value captured
Laboratory Janoshik Analytical
Document extracted · 90% confidence
Vials tested 3
Document extracted · 94% confidence
Provenance key Lab verifiedDocument extractedVendor statedManual review
PRODUCT RELATIONSHIP

Exact catalog attribution

The vendor and normalized product URL match the tracked catalog exactly. Name-only similarities are never promoted to this state.

02 / PANEL COVERAGE

Panel evidence and provenance

Lab-verified and document-extracted panels count as certificate coverage. Vendor-stated panels remain visible, but are not represented as results from this document.

● In document

HPLC / purity

Panel listed Document extracted
◆ Vendor stated only

Mass spectrometry / identity

Panel listed Vendor stated
◆ Vendor stated only

Measured quantity

Panel listed Vendor stated
◆ Vendor stated only

Sterility

Panel listed Vendor stated
◆ Vendor stated only

Endotoxin

Panel listed Vendor stated
○ Not extracted

Heavy metals

No result captured No provenance
1 of 6standard panels supported by this certificate · 4 vendor-stated claims shown separately
03 / LABORATORY

Verification surface

—
No provider lookup attached

Janoshik Analytical

This record currently relies on the vendor-hosted certificate and PB’s preserved copy. That is a weaker verification surface than a lab-controlled lookup.

View laboratory intelligence →
04 / INTEGRITY

Archive fingerprint

SHA-256546d5b0d45ae5572ac43d5b0790238aaac9c1d95bd14f0180474da6aaeecb712
First observed
Jul 28, 2026
Last observed
Sep 24, 2026
Captured
Sep 24, 2026
Attribution
Direct product evidence
Source host
peptidecrafters.com
05 / CHANGE HISTORY

Versions, changes, and reuse

The archive tracks source and content fingerprints over time, including replacements and certificates that later disappear from vendor sites.

Version family7 of 7

6 earlier observations retained.

Latest comparison1 changes

archive.sha256 updated.

Document reuse0 matches

No other current record shares this exact fingerprint.

Previous observations

Aug 13, 2026PC-G-TS10Open record →
Aug 11, 2026PC-G-TS10Open record →
Aug 10, 2026PC-G-TS10Open record →
Aug 10, 2026PC-G-TS10Open record →
Aug 4, 2026PC-G-TS10Open record →
Aug 4, 2026PC-G-TS10Open record →

Automated review signals

These explainable flags require human interpretation; they are not automated findings of misconduct.

mediumOne report identifier resolves to different document fingerprintsReview queue →lowMeasured quantity differs materially from the nearest declared valueReview queue →
06 / EVIDENCE ALERTS

Follow the evidence, not the marketing.

Get notified when a certificate appears, changes, goes stale, disappears, or loses a working laboratory-verification link.

Evidence watchChoose what to follow

One digest combines overlapping vendor and compound watches, so the same change reaches you once.

New here? Join Weekly Peptide Intel first. Already following evidence? Manage alerts. Alerts describe certificate changes—not product safety.